Radiesse Marks Key Milestone with Revealing Patient Survey Results
Merz Aesthetics, a division of Merz North America (U.S. affiliate of Merz Pharma Group) announced the 10-year anniversary of the launch of their flagship brand, RadiesseÒ. Radiesse is a volumizing filler used in more than 60 countries, and is unique in its ability to provide instant lift and stimulate the natural production of collagen with just one injection. More than 6 million syringes have been purchased by professionals worldwide over the past ten years.
In celebration of the brand’s 10-year anniversary, Merz Aesthetics issued a Patient Survey to Radiesse patients to learn more about their experiences with the product. Radiesse users were surveyed in June of 2016.
“The majority of polled Radiesse patients self reported that they consistently choose Radiesse even when given recommendations to try other fillers,” said Jim Hartman, Vice President and US Head of Merz Aesthetics Marketing and OTC.
“We look forward to continuing to deliver outstanding results to our loyal product users for years to come with the only volumizing filler shown to stimulate the natural production of collagen for a more refreshed appearance that can last up to a year or more in many patients.”
The Radiesse Patient Survey also revealed that Radiesse patients are very likely to recommend Radiesse to friends and family.
“Radiesse has been used for a decade and continues to make satisfied patients in my practice time after time,” said Dr Lawrence Bass, Medical Director, Bass Plastic Surgery PLLC. “When patients are choosing their filler products, they want natural-looking results, confidence and consistency in the outcome and a product they can trust. The positive results of this user survey are not surprising.”
Since its approval by the U.S. Food and Drug Administration (FDA) in 2006, Radiesse has provided a unique treatment option for moderate to severe facial wrinkles and folds such as nasolabial folds. Radiesse has proven to be an ideal volumizer, as it possesses higher levels of viscosity and elasticity than leading dermal fillers. It is differentiated by an advanced calcium-based microsphere technology that immediately replenishes lost volume and stimulates the production of a patient’s own natural collagen for long-lasting results.
Radiesse received U.S. FDA approval for hand augmentation to correct volume loss in the dorsum of the hands in June of 2015. Radiesse provides an immediate volumizing effect and can help to reduce the prominence of tendons and veins in the hands, delivering smooth, natural-looking results that can last up to 1 year.